Endoscopic and Cryoablation Denervation for Sacroiliac Joint Pain
SI-DEN
Prospective Study Evaluating Cryoablation and Endoscopic Denervation of the Dorsal Sacroiliac Joint Innervation (Ramus Dorsalis L5 and S1-S3) in Patients With Sacroiliac Joint Pain
1 other identifier
interventional
51
1 country
1
Brief Summary
This interventional study compares cryoablation and endoscopic denervation for the treatment of posterior sacroiliac joint pain in patients with chronic sacroiliac joint pain confirmed by a positive diagnostic block. The aim is to evaluate and compare the effectiveness of both procedures in reducing pain and improving functional status.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2026
CompletedFirst Submitted
Initial submission to the registry
March 15, 2026
CompletedFirst Posted
Study publicly available on registry
March 20, 2026
CompletedMarch 20, 2026
March 1, 2026
2 years
March 15, 2026
March 18, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Pain intensity measured by Numeric Rating Scale (NRS)
Change in pain intensity measured using an 11-point Numeric Rating Scale (0 = no pain, 10 = worst imaginable pain).
Baseline and 12 months follow-up
Functional disability measured by Oswestry Disability Index (ODI)
Change in functional disability assessed using the Oswestry Disability Index (0-100%, higher scores indicate greater disability).
Baseline and 12 months follow-up
Secondary Outcomes (3)
Change From Baseline EuroQol-5 Dimension (EQ-5D-5L) at 12 Months
Baseline and 12 months follow-up
Procedure-Related Complications
From procedure up to 24 months follow-up
Analgesic consumption measured as daily dose (mg/day)
Baseline and 12 months follow-up
Study Arms (2)
Cryoablation
EXPERIMENTALPatients with sacroiliac joint pain underwent cryoablation of the dorsal branches of L5 and S1-S3 after a positive diagnostic block confirming posterior sacroiliac joint pain.
Endoscopic Denervation
EXPERIMENTALPatients with sacroiliac joint pain underwent endoscopic denervation of the dorsal branches of L5 and S1-S3 after a positive diagnostic block confirming posterior sacroiliac joint pain.
Interventions
Percutaneous cryoablation of the dorsal branches of L5 and S1-S3 under imaging guidance for treatment of posterior sacroiliac joint pain after a positive diagnostic block.
Endoscopic denervation of the dorsal branches of L5 and S1-S3 for treatment of posterior sacroiliac joint pain after a positive diagnostic block.
Eligibility Criteria
You may qualify if:
- adults aged 18 years or older
- chronic sacroiliac joint pain
- positive sacroiliac joint provocation maneuvers
- positive diagnostic block of the dorsal branches of L5 and S1-S3 under fluoroscopic guidance
- at least 70% pain relief after diagnostic block
- ability to understand the study procedures and provide written informed consent
You may not qualify if:
- radicular pain caused by lumbar disc herniation or other dominant spinal pathology
- spinal tumor, infection, fracture, or inflammatory spinal disease
- coagulation disorder or ongoing anticoagulant therapy contraindicating the procedure
- pregnancy
- severe psychiatric or medical condition preventing reliable follow-up
- refusal to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
EuroPainClinics Košice
Košice, Košice Region, 04011, Slovakia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Masking Details
- This was an open-label study. Neither participants nor investigators were masked to the performed intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 15, 2026
First Posted
March 20, 2026
Study Start
April 20, 2023
Primary Completion
April 20, 2025
Study Completion
January 15, 2026
Last Updated
March 20, 2026
Record last verified: 2026-03